Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DOVW19
|
|||
| Drug Name |
Natrunix
|
|||
| Indication | Arthritis [ICD-11: FA20; ICD-9: 714] | Phase 2 | [1] | |
| Company |
XBiotech Austin, TX
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05363917) Phase II Double-Blinded, Placebo-Controlled Randomized Study Examining the Safety and Efficacy of Natrunix Versus Methotrexate (+Folate) for the Treatment of Rheumatoid Arthritis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.